OGFR Polyclonal Antibody

Rabbit Anti-OGFR Polyclonal Antibody

Product Specifications

Background

The opioid growth factor receptor encoded by OGFR is a receptor for opioid growth factor (OGF), also known as [Met (5) ]-enkephalin. OGF is a negative regulator of cell proliferation and tissue organization in a variety of processes. The encoded unbound receptor for OGF has been localized to the outer nuclear envelope, where it binds OGF and is translocated into the nucleus. The coding sequence of this gene contains a polymorphic region of 60 nt tandem imperfect repeat units. Several transcripts containing between zero and eight repeat units have been reported.

CAS Number

9007-83-4

Product Name Alternative

OGFR; Opioid growth factor receptor; OGFr; Protein 7-60; Zeta-type opioid receptor

Gene ID

11054

Accession Number

Q9NZT2

Reactivity

Human

Immunogen

Synthesized peptide derived from the Internal region of human OGFR at AA rangle: 110-190

Clonality

Polyclonal

Tag

Opioid growth factor receptor

Applications

WB, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

90kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

OGFR Polyclonal Antibody detects endogenous levels of OGFR protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; ELISA 1:20000; Not yet tested in other applications.